Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceuticals	1.54B	803.93M	32.32M
Pharmaceuticals Growth	91.62%	2387.26%	-
Total	1.54B	803.93M	32.32M
Total Growth	91.62%	2387.26%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
The PRC	7.54M	56.49M	20.39M
The PRC Growth	-86.64%	177.11%	-
The United States of America	1.53B	730.04M	-
The United States of America Growth	109.33%	-	-
Other Countries	4.73M	17.41M	11.94M
Other Countries Growth	-72.85%	45.83%	-
Total	1.54B	803.93M	32.32M
Total Growth	91.62%	2387.26%	-

Source: S&P Global Market Intelligence.